# FDA Inspection 732047 - Biomet North Central dba - June 28, 2011

Source: https://www.keypedia.com/records/fda_inspections/biomet-north-central-dba/4aff9e9c-216e-4983-a467-289e996a1cbf
Source feed: FDA_Inspections

> FDA Inspection 732047 for Biomet North Central dba on June 28, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 732047
- Company Name: Biomet North Central dba
- Inspection Date: 2011-06-28
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 907405 - 2014-12-19](https://www.keypedia.com/records/fda_inspections/biomet-north-central-dba/8cd253a9-f8fc-43dd-9a54-ca8ac2fd211e)
- [FDA Inspection 827833 - 2013-04-17](https://www.keypedia.com/records/fda_inspections/biomet-north-central-dba/b432e4b1-b316-4ffd-9d97-c1ea3757c2e6)
- [FDA Inspection 631517 - 2009-11-12](https://www.keypedia.com/records/fda_inspections/biomet-north-central-dba/967251c1-a9c6-4c03-91c7-b00c6f06cd17)

Company: https://www.keypedia.com/companies/biomet-north-central-dba/077aa77f-35e8-4137-9c34-749fa7f9e928

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d